The measures world governments enacted at the outset of the COVID-19 pandemic in early 2020…
PHARMA & CLINICAL TRIALS


Key takeaways Decreasing trend in opioid prescriptions: There was a notable nationwide reduction in opioid prescriptions…
/cloudfront-us-east-2.images.arcpublishing.com/reuters/KNWLDKTDOZLJLEMHF7XWSIMTHM.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/KNWLDKTDOZLJLEMHF7XWSIMTHM.jpg)
The U.S. Food and Drug Administration (FDA) on Thursday classified the recall of certain respiratory…


Alira Health and Sancare announced the launch of their partnership today. The companies are joining…


Accenture announced it has made a strategic investment, through Accenture Ventures, in QuantHealth, an AI-powered clinical…


AbbVie Launches PRODUODOPA for People Living with Advanced Parkinson’s Disease in the European Union
– PRODUODOPA (foslevodopa/foscarbidopa) is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment…
/cloudfront-us-east-2.images.arcpublishing.com/reuters/UIHKLYV3UJL4TJ4OBBFDNOID44.jpg)



